2m 2m 2m 2m 2m 2m 2m
BIOAGE LABS (BIOA)
NASDAQ
$22.33+$0.010 (+0.04%)
Price as of Jun 23, 2026 6:56 PM EDT- $954.4MMarket Cap
- 398.21%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOAGE LABS (BIOA)
$22.33+$0.010 (+0.04%)
BIOA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.32 | ||
Change | +$0.85 (+3.96%) | ||
Open | $20.90 | ||
High | $22.45 | ||
Low | $20.61 | ||
Previous Close | $21.47 | ||
Volume | 498,064 | ||
30-Day Average Volume | 472,643 | ||
1-Week Change | 8.93% | ||
1-Month Change | 34.38% | ||
1-Year Change | 398.21% | ||
3-Year Change | 13,858.72% | ||
5-Year Change | 13,858.72% | ||
Fundamentals | |||
Shares Outstanding | 44.5M | ||
Total Assets | $397.7M | ||
Market Cap | $954.4M | ||
Enterprise Value | $713.8M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$22.3M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$22.2M | ||
EBITDA | -$22.1M | ||
Net Working Capital | $376.0M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -32 | ||
Enterprise Value/Revenue | 257 | ||
P/B | 3 | ||
P/E | -41 | ||
PEG | -2 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue